Michael Stern Parkinsons Fdtn - NY New York, New York City 10010

Michael Stern Parkinsons Fdtn entered the industry of Medical Research in 2001 and has grown to employ 1 to 4 people, generating an annual revenue of $1.000.000 to $2.499.999. The NAICS classifies this business under the code 541720, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.

To acquire more information, please contact Margaret Stern by calling (646) 381-5144 during business hours. You can also write to the business’ Single Location at 1115 Broadway Floor 12, New York City, New York NY 10010. You can also visit the company’s website at alzinfo.org. View this business’ social media profiles on Twitter or on Facebbok .

Company: Michael Stern Parkinsons Fdtn
Representative: Margaret Stern
Place of Business: 1115 Broadway Floor 12, New York City, NY 10010
Contact Number: (646) 381-5144
Website: alzinfo.org
Type of Service: Medical Research
SIC Number: 8733
NAICS Number: 541720
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2001
Income/Year: $1.000.000 to $2.499.999
Laborers: 1 to 4
Share This Company:

Michael Stern Parkinsons Fdtn is a company operating from New York, New York providing professional Medical Research and relevant B2B variables. It was founded in 2001 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 541720 as Medical Research.

With a current employee count of 1 to 4, Michael Stern Parkinsons Fdtn has gone to report making $1.000.000 to $2.499.999 per annum on its journey towards growth. This company invites you to contact its representative Margaret Stern at (646) 381-5144 for related queries, or to locate its Single Location using the coordinates 40.742836,-73.989364.

The Single Location can also be found at the street address 1115 Broadway Floor 12 in New York City, New York 10010 and can be engaged online through the company website at alzinfo.org, the company Twitter , and Facebook page .